Galmed Pharmaceuticals Ltd. (GLMD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.63M | 19.72M | 21.08M | 16.3M | 16.12M | 17.68M | 10.08M | 11.18M | 13.24M | 14.2M | 9.79M | 12.83M |
| Cash & Short-Term Investments | 18.16M | 19.05M | 20.53M | 15.73M | 15.33M | 17.14M | 9.82M | 10.93M | 12.76M | 13.31M | 9.33M | 12.15M |
| Cash Only | 3.98M | 3.31M | 4.96M | 4.77M | 4.65M | 9.72M | 1.84M | 1.58M | 2.98M | 1.48M | 1.01M | 1.67M |
| Short-Term Investments | 14.17M | 15.74M | 15.56M | 10.96M | 10.68M | 7.42M | 7.99M | 9.35M | 9.78M | 11.83M | 8.32M | 10.48M |
| Accounts Receivable | 80K | 549K | 433K | 447K | 209K | 426K | 135K | 254K | 165K | 770K | 341K | 568K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.54K | 113.32K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 124K | 124K | 123K | 122K | 121K | 119K | 118K | 0 | 0 | 115K | 456 | 682 |
| Total Non-Current Assets | 0 | 1.86M | 1.86M | 2.39M | 2.38M | 3.27M | 3.27M | 3.34M | 3.39M | 3.44M | 3.49M | 1.96M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74K | 125K | 175K | 226K | 281K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 1.59M | 1.59M | 2.12M | 2.12M | 3.27M | 3.27M | 3.27M | 3.27M | 3.27M | 3.27M | 1.68M |
| Other Non-Current Assets | 0 | 267K | 267K | 267K | 257K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 18.63M | 21.58M | 22.94M | 18.68M | 18.5M | 20.95M | 13.34M | 14.52M | 16.63M | 17.64M | 13.28M | 14.79M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 0.69% | 3.03% | 71.98% | 28.67% | 11.25% | 18.78% | 0.48% | -1.83% | 0.41% | -15.48% | -43.68% | -51.02% |
| Total Current Liabilities | 2.85M | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M | 1.55M | 1.76M | 2.75M | 2.09M | 2.72M | 2.8M |
| Accounts Payable | 2M | 1.67M | 1.37M | 1.31M | 1.31M | 1.34M | 1.2M | 1.38M | 1.88M | 1.47M | 2.14M | 2.27M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 557K | 798K | 0 | 0 | 603K | 0 | 351K | 382K | 0 | 617K | 583K | 0 |
| Current Ratio | 6.55x | 7.98x | 8.71x | 9.02x | 7.42x | 7.03x | 6.48x | 6.34x | 4.81x | 6.79x | 3.59x | 4.58x |
| Quick Ratio | 6.55x | 7.98x | 8.71x | 9.02x | 7.42x | 7.03x | 6.48x | 6.34x | 4.81x | 6.79x | 3.55x | 4.54x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.85M | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M | 1.55M | 1.76M | 2.75M | 2.09M | 2.72M | 2.8M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41K | 0 | 0 | 0 |
| Net Debt | -3.98M | -3.31M | -4.96M | -4.77M | -4.65M | -9.72M | -1.84M | -1.58M | -2.94M | -1.48M | -1.01M | -1.67M |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -3.67x | - | - | - | - | -293.60x | - | - |
| Total Equity | 15.78M | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M | 11.79M | 12.76M | 13.88M | 15.55M | 10.55M | 11.99M |
| Equity Growth % | -3.34% | 3.67% | 74.12% | 32.31% | 17.64% | 18.58% | 11.68% | 6.39% | 3.4% | -1.28% | -49.04% | -50.79% |
| Book Value per Share | 2.40 | 3.50 | 5.20 | 9.48 | 10.16 | 266.71 | 22.47 | 2.34 | 2.75 | 2.49 | 6.28 | 7.14 |
| Total Shareholders' Equity | 15.78M | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M | 11.79M | 12.76M | 13.88M | 15.55M | 10.55M | 11.99M |
| Common Stock | 3.41M | 2.79M | 2.69M | 1.03M | 742K | 665K | 263K | 249K | 209K | 166K | 70K | 70K |
| Retained Earnings | -210.78M | -205.96M | -204.07M | -201.57M | -200.47M | -197.26M | -195.35M | -194.23M | -192.95M | -190.94M | -189.46M | -187.87M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -303K | -316K | -403K | -397K | -416K | -342K | -435K | -455K | -454K | -607K | -662K | -645K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |